Dr. Michal Sheleg joined Pluri in July 2017 and currently holds the position of Vice President of Clinical Development, where she oversees clinical programs, regulatory strategy, and the data department. Prior to her current role, she served as both a Research Manager and Medical Director at Pluri, contributing to the organization’s research and medical initiatives. Dr Sheleg completed her postdoctoral research at the Department of Neurobiology and Ethology in Haifa University. She holds a PhD in Toxicology from the University of Medicine and Dentistry of New Jersey and Rutgers, the State University of New Jersey Joint Graduate Program and holds a BS with Honors in Biology and Mathematics from Saint Peter’s University in NJ.

©2023 Pluri Inc.

©2023 Pluri Inc., its logo, brand, product, and process names appearing in this issue are the trademarks of Pluri™ Inc. or its affiliated companies. All other brand, product, and process names appearing are the trademarks of their respective holders. Reference to or use of a product, or process other than those of Pluri™ Inc. does not imply recommendation, approval, affiliation, or sponsorship of that product, or process by Pluri™ Inc. Nothing contained herein shall be construed as conferring by implication, estoppel, or otherwise any license or right under any patent, copyright, trademark, or other intellectual property right of Pluri™ Inc. or any third party, except as expressly granted herein.  All information herein is for general information only and is subject for change without notice.

NAME

Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.